Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Filana Therapeutics (FLNA) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Filana Therapeutics' Return on Capital Employed [ROCE] was -69.68% in Q2 2026, up 73.55 percentage points from -143.23% a year earlier and up 42.23 percentage points from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Filana Therapeutics came in at -101.36%, down 2.34 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for five consecutive years, with a five-year change of -90.06 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -99.02% in FY2024 (-39.84 pp), -59.18% in FY2023 (-26.35 pp), -32.83% in FY2022 (-13.27 pp) and -19.56% in FY2021 (-8.26 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] since Q3 2023.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in two of the last eight quarters, with an average year-over-year change of -9.71 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 73.55 percentage points); the worst was Q1 2024 (a drop of 88.06 percentage points).
  • Per Business Quant data, FLNA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -111.91% (Q1 2026), -118.93% (Q4 2025) and -131.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 17.52%
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 17.92%
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn 6.28%
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 19.32%
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 16.76%
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -5.97%
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 11.86%
10 Filana Therapeutics 31.16 Mn -339.67 Mn - -69.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.68%
Mar 31, 2026 -111.91%
Dec 31, 2025 -118.93%
Sep 30, 2025 -131.73%
Jun 30, 2025 -143.23%
Mar 31, 2025 -107.43%
Dec 31, 2024 -79.07%
Sep 30, 2024 -76.29%
Jun 30, 2024 -91.01%
Mar 31, 2024 -129.79%
Dec 31, 2023 -71.64%
Sep 30, 2023 -62.16%
Jun 30, 2023 -51.41%
Mar 31, 2023 -41.73%
Dec 31, 2022 -37.39%
Sep 30, 2022 -35.18%
Jun 30, 2022 -27.28%
Mar 31, 2022 -18.96%
Dec 31, 2021 -12.74%
Sep 30, 2021 -7.75%
API Access

Filana Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FLNA&period=max&api_key=YOUR_API_KEY